Gianluca Pecetti

The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist

Paola Cipriani, Paola Di Benedetto, Piero Ruscitti et al. · The Journal of Rheumatology · 2015 · 119 citations

Veterinary Medicine, Cell Biology, Pathobiology +17

Sarcopenia in systemic sclerosis: the impact of nutritional, clinical, and laboratory features

Claudio Corallo, Antonella Fioravanti, Sara Tenti et al. · Rheumatology International · 2019 · 52 citations

Medicine, Nutrition, Nutritional Sciences +14

Bosentan and macitentan prevent the endothelial-to-mesenchymal transition (EndoMT) in systemic sclerosis: in vitro study

Claudio Corallo, Maurizio Cutolo, Bashar Kahaleh et al. · Arthritis Research & Therapy · 2016 · 35 citations · Full text

Veterinary Medicine, Clinical Sciences, Pathobiology +16

Cytokine modulation by endothelin-1 and possible therapeutic implications in systemic sclerosis.

N. Giordano, Panagiotis Papakostas, Gianluca Pecetti et al. · PubMed · 2012 · 17 citations

Veterinary Medicine, Immunology, Pathology +17

Macitentan slows down the dermal fibrotic process in systemic sclerosis: in vitro findings.

Claudio Corallo, Gianluca Pecetti, Marc Iglarz et al. · PubMed · 2013 · 12 citations

Medicine, Pathology, Pharmacology +17